Gustav Christensen
Chairman chez MORPHIC HOLDING, INC.
Fortune : 4 M $ au 31/03/2024
Profil
Gustav A.
Christensen is currently the Chairman at Morphic Therapeutic, Inc., Chairman at Morphic Holding, Inc., President, Treasurer & Director at Phytera, Inc., and Independent Director at Generation Bio Co. Previously, he held positions such as President, Chief Executive Officer & Director at Dyax Corp., Chairman at Alpha-Beta Technology, Inc., Managing Director at Apeiron Partners LLC, Vice President-Business Development at Genetics Institute LLC, President at ImmuLogic Pharmaceutical Corp., Advisor at BioVentures Investors, Member-Management Board at Alantos Pharmaceuticals AG, and Vice President-Operations Fenwal Laboratories at Baxter International, Inc. He has a graduate degree from the University of Aarhus and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
0,20% | 01/06/2023 | 100 517 ( 0,20% ) | 4 M $ | 31/03/2024 |
GENERATION BIO CO.
0,20% | 08/06/2023 | 131 422 ( 0,20% ) | 534 888 $ | 31/03/2024 |
Postes actifs de Gustav Christensen
| Sociétés | Poste | Début |
|---|---|---|
| MORPHIC HOLDING, INC. | Chairman | 01/04/2016 |
| GENERATION BIO CO. | Director/Board Member | 01/12/2017 |
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | President | - |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Chairman | - |
Anciens postes connus de Gustav Christensen
| Sociétés | Poste | Fin |
|---|---|---|
| DYAX CORP. | Chief Executive Officer | 22/01/2016 |
BioVentures Investors
 BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | Private Equity Investor | 31/03/2009 |
Apeiron Partners LLC
 Apeiron Partners LLC Investment ManagersFinance Apeiron Partners LLC provides investment advice. The private company is based in Boston, MA. The company was founded by Jeffrey D. Wager. | Corporate Officer/Principal | 01/01/2007 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1988 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1983 |
Formation de Gustav Christensen
| University of Aarhus | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| GENERATION BIO CO. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
Alpha-Beta Technology, Inc.
 Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Alpha-Beta Technology, Inc. engages in the discovery, development and commercialization of novel carbohydrate-based products for the prevention and treatment of infectious disease. It develops a novel class of immune modulation pharmaceutical products composed of complex carbohydrates and is discovering and developing new anti-fungal diagnostics and drugs. In addition, Alpha-Beta has developed a rapid in vitro diagnostic to detect and monitor systemic fungal infections and has an anti-fungal research program to discover direct inhibitors of fungal cell wall synthesis. It is in the development stage and is devoting substantially all of its efforts toward product research and development, raising capital, marketing products under development, clinical trials and manufacturing. The Company was founded on March 2, 1988 and is headquartered in Worcester, MA. | Electronic Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Phytera, Inc.
Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | Commercial Services |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | Finance |
Alantos Pharmaceuticals AG
 Alantos Pharmaceuticals AG BiotechnologyHealth Technology Alantos Pharmaceuticals AG develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases. The company was founded in 1999 and is headquartered in Heidelberg, Germany. | Health Technology |
Apeiron Partners LLC
Apeiron Partners LLC Investment ManagersFinance Apeiron Partners LLC provides investment advice. The private company is based in Boston, MA. The company was founded by Jeffrey D. Wager. | Finance |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
